TY - JOUR
T1 - Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein
T2 - A mechanism for the generation of highly reactive α-hydroxy and α,β-unsaturated aldehydes by phagocytes at sites of inflammation
AU - Anderson, Melissa M.
AU - Hazen, Stanley L.
AU - Hsu, Fong F.
AU - Heinecke, Jay W.
PY - 1997/2/1
Y1 - 1997/2/1
N2 - Reactive aldehydes derived from reducing sugars and lipid peroxidation play a critical role in the formation of advanced glycation end (AGE) products and oxidative tissue damage. We have recently proposed another mechanism for aldehyde generation at sites of inflammation that involves myeloperoxidase, a heme enzyme secreted by activated phagocytes. We now demonstrate that human neutrophils employ the myeloperoxidase-H2O2-chloride system to produce α-hydroxy and α,β-unsaturated aldehydes from hydroxy- amino acids in high yield. Identities of the aldehydes were established using mass spectrometry and high performance liquid chromatography. Activated neutrophils converted L-serine to glycolaldehyde, an α-hydroxyaldehyde which mediates protein cross-linking and formation of N(ε)(carboxymethyl)lysine, an AGE product. L-Threonine was similarly oxidized to 2-hydroxypropanal and its dehydration product, acrolein, an extremely reactive α,β-unsaturated aldehyde which alkylates proteins and nucleic acids. Aldehyde generation required neutrophil activation and a free hydroxy-amino acid; it was inhibited by catalase and heme poisons, implicating H2O2 and myeloperoxidase in the cellular reaction. Aldehyde production by purified myeloperoxidase required H2O2 and chloride, and was mimicked by reagent hypochlorous acid (HOCl) in the absence of enzyme, suggesting that the reaction pathway involves a chlorinated intermediate. Collectively, these results indicate that the myeloperoxidase-H2O2-chloride system of phagocytes converts free hydroxy-amino acids into highly reactive α-hydroxy and α,β-unsaturated aldehydes. The generation of glycolaldehyde, 2- hydroxypropanal, and acrolein by activated phagocytes may thus play a role in AGE product formation and tissue damage at sites of inflammation.
AB - Reactive aldehydes derived from reducing sugars and lipid peroxidation play a critical role in the formation of advanced glycation end (AGE) products and oxidative tissue damage. We have recently proposed another mechanism for aldehyde generation at sites of inflammation that involves myeloperoxidase, a heme enzyme secreted by activated phagocytes. We now demonstrate that human neutrophils employ the myeloperoxidase-H2O2-chloride system to produce α-hydroxy and α,β-unsaturated aldehydes from hydroxy- amino acids in high yield. Identities of the aldehydes were established using mass spectrometry and high performance liquid chromatography. Activated neutrophils converted L-serine to glycolaldehyde, an α-hydroxyaldehyde which mediates protein cross-linking and formation of N(ε)(carboxymethyl)lysine, an AGE product. L-Threonine was similarly oxidized to 2-hydroxypropanal and its dehydration product, acrolein, an extremely reactive α,β-unsaturated aldehyde which alkylates proteins and nucleic acids. Aldehyde generation required neutrophil activation and a free hydroxy-amino acid; it was inhibited by catalase and heme poisons, implicating H2O2 and myeloperoxidase in the cellular reaction. Aldehyde production by purified myeloperoxidase required H2O2 and chloride, and was mimicked by reagent hypochlorous acid (HOCl) in the absence of enzyme, suggesting that the reaction pathway involves a chlorinated intermediate. Collectively, these results indicate that the myeloperoxidase-H2O2-chloride system of phagocytes converts free hydroxy-amino acids into highly reactive α-hydroxy and α,β-unsaturated aldehydes. The generation of glycolaldehyde, 2- hydroxypropanal, and acrolein by activated phagocytes may thus play a role in AGE product formation and tissue damage at sites of inflammation.
KW - Advanced glycation end product
KW - Atherosclerosis
KW - Diabetes mellitus
KW - Hypochlorous acid
KW - Oxidation- reduction
UR - http://www.scopus.com/inward/record.url?scp=0030854261&partnerID=8YFLogxK
U2 - 10.1172/JCI119176
DO - 10.1172/JCI119176
M3 - Article
C2 - 9022075
AN - SCOPUS:0030854261
SN - 0021-9738
VL - 99
SP - 424
EP - 432
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 3
ER -